Leadership
The SNBL CPC vision is dynamically executed throughout every phase of the operation—from the top down. Key leadership at SNBL CPC continues the successful tradition of parent company Shin Nippon Biomedical Laboratories, Ltd., Japan's largest and oldest CRO. Striving to offer the highest quality research services at every stage of the drug-development process, the SNBL CPC team brings a wealth of research experience and a collaborative spirit that uniquely positions the organization as a true champion for your pharmaceutical development initiatives.
Clinical Research Department
Mohamed S. Al-Ibrahim
Chief Medical Officer & President [CV-PDF]
Patrick R. Ayd
Chief Operating Officer
Dan Rudin
Medical Director [CV-PDF]
Mary Unruh
Director of Operations [CV-PDF]
Masaru Kaneko
Research Physician [CV-PDF]
Client Service & Partnership
Patrick R. Ayd
Chief Operating Officer
George Debski
Vice President of Business Development
Chris Hickey
Director of Business Development
Corporate Management
Ryoichi Nagata
Chairman of SNBL Clinical Pharmacology Center, Inc.
CEO, SNBL Group Companies
Ryoichi Nagata, M.D., Ph.D., is the Chairman of SNBL Clinical
Pharmacology Center, Inc. He heads SNBL Global Group as CEO & President, which includes
serving as Chairman of SNBL USA, Ltd. (Everett, WA). [more...]
Takeshi Yamakawa
CEO of SNBL Clinical Pharmacology Center, Inc.
Takeshi Yamakawa, the CEO of SNBL Clinical Pharmacology Center, Inc., is in charge of strategic and daily corporate management of SNBL CPC, Inc. He developed business strategy and plans, and executed them to establish the growing business from the ground up. He has once again joined the SNBL Clinical Pharmacology Center team as CEO, and continues to provide creative and strategic vision to keep SNBL Clinical Pharmacology Center at the forefront of research clinics.[more...]
|
Print